Palos Cancer Program Receives National Recognition
Palos Community Hospital’s Cancer Program has earned a three-year approval with Commendation from the American College of Surgeons Commission on Cancer.
The Commission sets quality-of-care standards for cancer programs and ensures that health care providers conform to those standards. Approval by the Commission is given to those programs that have voluntarily committed to providing the highest quality of cancer care, and that undergo a rigorous evaluation process and review of their performance.
To maintain this endorsement, organizations with Commission approved cancer programs must undergo an on-site review every three years. Receiving care at a Commission-approved facility such as Palos Community Hospital ensures that patients have access to:
- Comprehensive care, including a range of state-of-the-art services and equipment;
- A multi-specialty team approach to coordinate the best treatment options;
- Information about ongoing clinical trials and new treatment options, as well as cancer-related information, education and support;
- A cancer registry that collects data on the types and stages of cancers and treatment results, and that offers lifelong patient follow-up;
- Ongoing monitoring and improvement of care; and
- Quality care close to home.
“We are very pleased that the Cancer program at Palos Community Hospital has once again achieved this level of recognition,” says Radiation Oncologist S. Javed Shirazi, M.D., Chairman of the Palos Oncology Committee for the Commission on Cancer. ”Patients can be assured that the cancer outcomes here at Palos are comparable to hospitals across the country.” Palos Community Hospital’s Cancer program involves a number of physicians from a variety of specialties, as well as several hospital departments, including:
- Cancer Registry (a division of Medical Records),
- Quality Assessment,
- Pastoral Care,
- Social Services,
“A multidisciplinary team of physicians and staff members at Palos Community Hospital regularly participate in Oncology Committee meetings and Tumor Board Case Presentations, in which patient cases are discussed in depth,” explains Surgeon Thomas J. Vasdekas, M.D., F.A.C.S., Oncology Committee Physician Liaison. “This recognition is the result of the deep commitment of all members of the cancer care team to providing the best possible outcomes for patients at Palos.”
Of the more than 1,400 institutions that are surveyed by the Commission on Cancer, fewer that 50 percent receive a three year commendation.